Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-17-000203
Filing Date
2017-02-10
Accepted
2017-02-10 08:54:37
Documents
3
Period of Report
2017-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 10616
2 NEWS RELEASE DATED FEBRUARY 10, 2017 ex991.htm EX-99.1 7649
3 GRAPHIC image_001.jpg GRAPHIC 9382
  Complete submission text file 0001279569-17-000203.txt   32334
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 17589774
SIC: 2834 Pharmaceutical Preparations